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        In the adaptive immune system, multiple barriers 
minimize the likelihood that a randomly gener-
ated antigen receptor will recognize and initi-
ate a response to self-peptide. These barriers are 
at work throughout the lifetime of antigen 
receptor  –  bearing cells, starting with the elimina-
tion of self-reactive cells during their develop-
ment and followed by mechanisms that induce 
anergy, suppression, or apoptosis of any self-re-
active cells escaping to the periphery (  1  –  3  ). In 
some rare, inherited autoimmune syndromes, 
single-gene defects trigger a failure of one of these 
processes. However, for most autoimmune dis-
eases, including lupus and arthritis, multiple in-
teracting loci with relatively small individual 
eff  ects are generally necessary for disease patho-
genesis (  4  ). Studying how genetic modifi  ers 
cooperate to cause disease is thus critical to our 
understanding of autoimmunity. 
  CD45 plays an essential role in the immune 
system, regulating lymphocyte development and 
activation through Src family kinases (SFKs) (  5  ). 
CD45 maintains SFKs in a primed, quiescent 
state by dephosphorylating both inhibitory and 
activating tyrosines. These unphosphorylated 
SFKs assume an open conformation that can be 
rapidly activated by phosphorylation of the ac-
tivation loop tyrosine (  6  ). In the absence of 
CD45 activity, the inhibitory tyrosine is phos-
phorylated by the kinase Csk, and the SFK 
adopts a closed, inactive conformation. 
  One means of regulating CD45 is by spon-
taneous homodimerization, which inhibits its 
activity, preventing SFK activation and antigen 
receptor signaling (  7, 8  ). The crystal structure of 
a related phosphatase, receptor protein tyrosine 
phosphatase       (RPTP     ), revealed a possible 
mechanism for inhibition by dimerization. The 
membrane-proximal phosphatase domain of 
RPTP      crystallizes as a symmetric dimer in 
which a helix-turn-helix motif of one   molecule 
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  CD45 and Fas regulate tyrosine phosphorylation and apoptotic signaling pathways, re-
spectively. Mutation of an inhibitory wedge motif in CD45 (E613R) results in hyperre-
sponsive thymocytes and B cells on the C57BL/6 background, but no overt autoimmunity, 
whereas Fas deletion results in a mild autoimmune disease on the same genetic back-
ground. In this study, we show that these two mutations cooperate in mice, causing early 
lethality, autoantibody production, and substantial lymphoproliferation. In double-mutant 
mice, this phenotype was dependent on both T and B cells. T cell activation required 
signaling in response to endogenous or commensal antigens, demonstrated by the intro-
duction of a transgenic T cell receptor. Genetic deletion of B cells also prevented T cell 
activation. Similarly, T cells were necessary for B cell autoantibody production. However, 
B cells appeared to be intrinsically activated even in the absence of T cells, suggesting 
that they may drive the phenotype of these mice. These results reveal a requirement for 
careful control of B cell signaling and cell death in preventing inappropriate lymphocyte 
activation and autoimmunity. 
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WT, single-, and double-mutant backgrounds over the course 
of 1 yr. Of these cohorts, wedge/  lpr   double-mutant mice 
showed accelerated autoantibody production and mortal-
ity. 100% of wedge/  lpr   mice developed antinuclear anti-
bodies (ANAs) by 2 mo of age, dsDNA antibodies by 3 mo, 
and died by 9 mo (  Fig. 1, A  –  C  ).   As previously reported, B6 
  Lpr   mice did not develop low-titer ANAs until 6 mo of 
age and dsDNA antibodies until 9 mo of age (unpublished 
data) (  18  ). In contrast, autoantibodies were not detected 
in wedge, C4, and wedge/C4 mice throughout the year-
long experiment. 
  In MRL/  lpr   mice, autoantibodies and early death are often 
linked to antibody deposition in the kidneys and glomerulo-
nephritis. Proteinuria is commonly used as a marker for kid-
ney damage in these mice, but surprisingly neither immune 
complex deposition nor proteinuria were detected in CD45 
wedge/  lpr   mice as late as 9 mo of age (unpublished data). His-
tological examination of kidneys from 6  –  9-mo-old wedge/  lpr   
mice did, however, reveal increasing amounts of perivascular 
lymphocyte accumulations with age. The accumulations were 
most prominent in kidney and lung and, to a lesser extent, the 
liver (  Fig. 1, D and E  ). We speculate that progressive accumula-
tion of lymphocytes, combined with compression of the lungs 
forms a   “  wedge  ”  and inserts into the catalytic site of the part-
ner molecule (  9  ). The wedge is highly conserved in CD45. 
Mutating the acidic amino acid at its tip prevented dimerization-
mediated inhibition in vitro and, moreover, led to a lupus-like 
syndrome in mice when knocked into the endogenous CD45 
locus (E613R) (  8, 10  ). In a mixed C57BL/6 (B6) and 129 genetic 
background, the CD45 wedge mutant mice develop a pro-
nounced lymphoproliferative disease (LPD), autoantibodies, and 
immune complex  –  mediated glomerulonephritis (  10  ). However, 
as with many autoimmune phenotypes, much of the disease re-
solved on a homogenous B6 background (  11  ). B6 CD45 wedge 
mice still develop very mild lymphoproliferation and elevated 
IgM levels, but autoantibodies and glomerulonephritis are absent. 
B cells remain hyperresponsive to various stimuli, suggesting that 
the CD45 wedge mutant behaves as a hypermorphic allele, but is 
insuffi   cient to cause autoimmunity on the B6 background. 
  In this study, we ask whether the wedge mutation could act 
as a genetic modifi  er with other mutations, predisposing mice, 
and potentially humans, to autoimmunity. We chose to study 
the complement C4 knockout and a naturally occurring Fas 
mutation,   lpr,   based on their ability to induce a mild, slowly 
progressing autoimmunity on the B6 background. Comple-
ment is a component of the innate immune system involved in 
opsonization and clearance of pathogens and possibly apop-
totic bodies (  12, 13  ). Fas, when bound by Fas ligand (FasL), 
frequently triggers apoptosis on activated cells, and hence is 
part of the activation-induced cell death (AICD) pathway. In 
mice, the phenotypes of the C4 knockout and   lpr   mutation are 
highly dependent on strain background. Both mixed B6   ×   129 
C4 knockout and MRL/  lpr   mice develop robust autoimmune 
lupus-like disease, characterized by lymphocyte activation, 
autoantibodies against nuclear components, immune complex 
deposition, and glomerulonephritis (  13  –  18  ). However, back-
crossing both C4 and   lpr   to the B6 background mitigates most 
of their phenotype. In these mice, low levels of autoantibody 
are detected only in older mice, without evidence of overt or-
gan damage (  18, 19  ). Here, we fi  nd that combination of C4 
defi  ciency and the CD45 wedge mutation does not alter dis-
ease compared with single-mutant mice. However, the wedge 
mutation and   lpr   act synergistically, markedly accelerating au-
toantibody production, lymphocyte activation, and lymphopro-
liferation. Thus, the CD45 wedge mutation acts as a potent 
modifi  er with the   lpr   mutation, but not C4 defi  ciency. In 
addressing the mechanisms behind the wedge/  lpr   phenotype, 
we further demonstrate that T cells, and specifi  cally signaling 
through the TCR, and B cells are required for lymphoprolifer-
ation, suggesting the presence of a positive feedback loop be-
tween these two cell types. Moreover, B cells appear to be 
intrinsically activated, and therefore their activation may be the 
primary event driving lymphocyte activation and expansion. 
    RESULTS AND DISCUSSION   
  CD45 wedge/  lpr   mice die at an accelerated rate 
with autoantibody production 
  We generated wedge/  lpr   double-mutant mice and followed 
cohorts consisting of 10 mice, 5 male and 5 female, from 
    Figure 1.         CD45 wedge/  lpr   double-mutant mice show early lethal-
ity and autoantibody production.   (A) Kaplan-Meier survival curve from 
aging cohorts.   n   = 10 mice per group, 5 males and 5 females. P   <   0.0005. 
(B) Anti-dsDNA ELISA of serum from aging mice, 6  –  10 mice per group. 
Error bars represent SEM. Analysis of variance (ANOVA): *, P   <   0.05; **, P   <   
0.005; ***, P   <   0.0005. (C) Staining of Hep2 nuclei with serum diluted 1:40 
from 2-mo-old animals. Images are representative of three animals per 
group. Bars, 50   μ  m. Lymphocyte accumulation in kidney (D) and lungs 
(E) of 6-mo-old CD45 wedge/  lpr  mice. Bars, 200   μ  m.     JEM VOL. 205, November 24, 2008  2757
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lineages were also activated, as measured by MHC class II 
and CD86 up-regulation, in wedge/  lpr   mice relative to 
controls (  Fig. 3 B  ). 
  The wedge mutation does not enhance AICD 
or proliferation in vitro 
  We next set out to understand the mechanism driving the 
T cell activation and expansion in the CD45 wedge/ lpr   double-
mutant mice. Based on our observations that wedge B cells 
are hyperresponsive to stimulation, we hypothesized that wedge 
T cells might also have a reduced threshold for activation 
and thus be more susceptible to Fas-mediated AICD (  11  ). 
from mediastinal lymphadenopathy, contribute to the death of 
wedge/  lpr   mice from asphyxiation (Fig. S1, A  –  C, available at 
http://www.jem.org/cgi/content/full/jem.20081204/DC1). 
Immunohistochemical analysis revealed the cells to consist al-
most exclusively of CD3  +   and CD4  +   T cells (Fig. S1, D  –  G). 
In addition to the perivascular infi  ltrates, kidneys from older 
wedge/  lpr   mice appeared pale and contained enlarged, hy-
percellular glomeruli, which could represent early, subclinical 
renal ischemia (Fig. S1, H  –  K). 
  Wedge and   lpr   mutations cooperate to induce lymphocyte 
activation and expansion 
  On gross examination, the most striking feature of wedge/  lpr   
mice was marked lymphadenopathy and splenomegaly, which 
progressed with age (Fig. S1, A and B). Both splenic weight 
and lymph node cellularity in wedge/  lpr   double-mutant mice 
were increased up to 10-fold compared with single-mutant 
and WT mice ( Fig. 2, A and B  ).   The breakdown of lympho-
cyte subsets is shown in   Fig. 2 C  . In general, the composition 
of lymphocytes in wedge/  lpr   mice is similar to that of wedge 
mice, which have a greater fraction of CD3 versus CD19 cells 
and a slightly skewed CD4 to CD8 ratio. The notable excep-
tions are the reduced percentage of CD4 and, more dramati-
cally, CD8 cells as they are replaced by the substantial increase 
in CD3  +   CD4/CD8 double-negative (DN) T cells. This is a 
unique subset of T cells found in   lpr   mice, but is much more 
prominent in wedge/  lpr   mice. The origin of these DN cells is 
controversial, but they are believed to represent a population 
of activated T cells that fail to undergo AICD as a result of the 
Fas mutation (  17, 18  ). Although the percentage of some sub-
sets was reduced, the absolute number of all lymphocyte sub-
sets was much higher in wedge/  lpr   mice as a result of the 
overall increased cellularity (  Fig. 2 D  ). Based on BrdU incor-
poration, lymphocyte expansion was a consequence of in-
creased proliferation in vivo. In wedge/  lpr   mice,     60% of 
CD4  +   T cells, CD8  +   T cells, and CD19 B cells, had divided 
and incorporated BrdU over 10 d, a signifi  cantly higher per-
centage than wedge,   lpr  , and WT cells (  Fig. 2 E  ). 
  Fitting with the observed lymphoproliferation, both pe-
ripheral T and B wedge/  lpr   cells were activated at a higher 
frequency. In 2-mo-old mice, up to 90% of CD4 and 75% 
of CD8 T cells in the spleen had already acquired a memory 
phenotype, defi  ned by up-regulation of CD44 (  Fig. 3 A   and 
Fig. S2 A, available at http://www.jem.org/cgi/content/
full/jem.20081204/DC1).   An unusual population of CD4 
cells found in   lpr   mice that have up-regulated CD44, but 
failed to down-regulate CD62L, was likewise expanded in 
wedge/  lpr   double mutants. The wedge/  lpr   memory pheno-
type cells showed a strong Th1 polarization. A large fraction 
of wedge/  lpr   CD4  +   CD44  high   cells produced IFN-     , but not 
IL-4 or -17, upon direct ex vivo stimulation with PMA and 
ionomycin (Fig. S2 C and not depicted). In addition to in-
creased memory cell markers, wedge/  lpr   mice have a higher 
fraction of cells expressing the immediate activation marker 
CD69 (Fig. S2 B), which is suggestive of ongoing T cell ac-
tivation. Analysis of B and myeloid cells indicates that these 
    Figure 2.         Lymphocyte expansion in CD45 wedge/  lpr   mice is ac-
companied by increased cell proliferation.   (A) Splenic weight of 2-, 4-, 
and 6-mo-old mice. Mean of three to six mice per time point   ±   SEM. 
ANOVA: *, P   <   0.05; **, P   <   0.005; ***, P   <   0.0005. (B) Total number of cells 
pooled from inguinal, axillary, brachial, cervical, and mesenteric lymph 
nodes of 2-mo-old mice. Unpaired Student  ’  s   t   test: ***, P   <   0.0005. 
(C) Lymphocyte subset analysis of lymph nodes from 2-mo-old mice. 
CD3  +   cells are separated into CD4  + ,  CD8 +  , and DN (CD3  + ,  B220 + ,  CD4      /
CD8         [DN]) cells. (D) Mean absolute number of T cell subsets and B cells 
in lymph nodes from 2-mo-old mice. Error bars represent SEM with two 
to four mice per group from three independent experiments. (E) BrdU 
incorporation is increased in CD4 and CD8 T cells and B cells from wedge/
  lpr  mice. 7  –  8-wk-old mice were given BrdU in their drinking water for 10 d. 
Shown is the mean percentage of cells positive for intracellular BrdU from 
four mice per genotype   ±   SEM. Data are representative of three indepen-
dent experiments. (C, D, and E) Unpaired Student  ’  s   t   test,  P   <   0.05  com-
pared with WT, *; wedge, **; and   lpr ,  ***.   2758 AUTOIMMUNITY IN CD45 WEDGE AND FAS MUTANT MICE   | Gupta et al. 
jem.20081204/DC1). Restricting the TCR repertoire also 
corrected the lymphadenopathy and splenomegaly, as well as 
the survival defect seen in wedge/  lpr   mice (  Fig. 4 A  ). None 
of the mice in a cohort of 6 wedge/  lpr   OT2 mice had died at 
6 mo compared with the 50% mortality seen at this time point 
in nontransgenic wedge/  lpr   mice (unpublished data). Genetic 
elimination of T cells using TCR            /       mice also prevented 
lymphadenopathy and splenomegaly (  Fig. 4 A  ). Furthermore, 
wedge/  lpr   TCR            /       mice failed to produce autoantibodies 
by 5 mo of age (unpublished data). Wedge/  lpr   B cells must 
therefore require T cell help to expand and secrete autoanti-
bodies. Interestingly, B cells and DCs from wedge and wedge/  lpr   
TCR            /       mice still expressed higher levels of MHC class II 
and CD86, suggesting that B cell and DC activation is a T 
cell  –  independent eff  ect that results mainly from the wedge 
mutation alone (  Fig. 4 C  ). 
  This fi  nding led us to hypothesize that B cell activation 
may be responsible for initiating the lymphoproliferation in 
wedge/  lpr   mice. We therefore crossed the      MT mutation 
(Ig       /      ) onto wedge/  lpr   mice to eliminate B cells and found 
that the extent of T cell activation was signifi  cantly reduced 
(  Fig. 5 A  ).   The percentage of memory phenotype T cells in 
wedge/  lpr   Ig       /       mice was similar to that of   lpr   Ig       /       T cells, 
suggesting that wedge/  lpr   B cells play a role in the activation 
of T cells. Removal of B cells also reduced the rate of BrdU 
incorporation in wedge/  lpr   T cells by 50%, which is   consistent 
Surprisingly, in vitro AICD assays did not   reveal any diff  erences 
in the apoptosis of wedge versus WT T cells (Fig. S3, available 
at http://www.jem.org/cgi/content/full/jem.20081204/DC1). 
  lpr   and wedge/  lpr   T cells were resistant to death in these ex-
periments, indicating that induction of death was Fas depen-
dent (Fig. S3 and not depicted). There was also no diff  erence 
in CD3 plus CD28  –  induced in vitro proliferation of CD4 or 
CD8 T cells from young mice among the four genotypes at 
multiple doses and time points (unpublished data). These re-
sults raised the possibility that the wedge mutation has dif-
ferent eff  ects on responses to strong in vitro stimulation versus 
in vivo endogenous signals. 
  TCR antigen recognition and B cells are required 
for lymphoproliferation 
  To examine the role of endogenous signaling through the 
TCR, we restricted the T cell repertoire to a single TCR us-
ing the ovalbumin peptide  –  reactive OT2 TCR transgene. 
The OT2 TCR transgene completely eliminated the pres-
ence of memory phenotype T cells in wedge/  lpr   mice (  Fig. 4 B  ).   
In these mice, the small fraction of T cells escaping OT2 
TCR restriction showed a slight increase in the percentage of 
memory cells compared with WT OT2. The degree of acti-
vation in these cells likely depends on the specifi  c TCR trans-
gene, the effi   ciency of restriction, and the strain background 
(Fig. S4, available at http://www.jem.org/cgi/content/full/
    Figure 3.         T and B cells from wedge/  lpr   mice show signs of activation.   (A) Representative fl  ow cytometric analysis of CD4 memory phenotype cells 
from 2-mo-old mice. Shown are the percentage of CD3  +   CD4 +   T cells from lymph node and spleen that are memory (CD44  high ,  CD62L low/high  ) and naive 
(CD44  low ,  CD62L high  ) cells. Data are representative of two to four mice from three independent experiments. (B) MHC class II and CD86 expression on 
CD19  +   B cells and CD11c  +   DCs are shown as the mean MFI for two to four mice per genotype   ±   SEM. Data are shown as relative MFI to correct for differ-
ent antibody clones and fl  uorophores and are representative of three independent experiments. Unpaired Student  ’  s   t   test P   <   0.05 compared with WT, *; 
wedge, **; and   lpr ,  ***.   JEM VOL. 205, November 24, 2008  2759
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low-level signal required for maintaining naive cell survival, en-
hanced signaling in CD45 wedge mutant cells chronically acti-
vates a subset of these cells. Several recent studies have suggested 
that Fas deletes such chronically activated cells. In these studies, 
deleted cells were activated in response to either endogenous 
antigens (  21, 22  ) or persistent foreign antigens (  23  –  25  ). Fas is 
likely to be important in deleting wedge mutant T and B cells 
activated by endogenous antigens as well. However, once Fas is 
removed, these cells survive and proliferate. 
  Although both T and B cells show increased activation and 
turnover in wedge/  lpr   mice, neither cell type alone is suffi   cient 
to cause lymphoproliferation. Neither T cell  –   or B cell  –  defi  cient 
wedge/  lpr   mice develop lymphadenopathy or splenomegaly. This 
phenomenon has also been previously documented for B cell 
defi  ciency in mixed background wedge mutant mice, MRL/  lpr   
mice, and aged B6/  lpr   mice, which fail to develop lymphade-
nopathy, splenomegaly, and glomerulonephritis (  11, 26  –  28  ). 
with B cells contributing to the proliferation of T cells (  Fig. 5 B  ). 
In addition, the absence of B cells markedly abrogated lymph-
adenopathy and splenomegaly (  Fig. 4 A  ) and rescued wedge/
  lpr   Ig       /       mice from premature death. 6 out of 6 mice in a 
cohort of wedge/  lpr   Ig       /       mice were healthy at 6 mo (un-
published data). Thus, in contrast to the intrinsic activation of 
wedge/  lpr   B cells, T cells appear to be dependent on B cells 
for both activation and expansion. 
  Based on our data, we propose the following model for the 
roles of CD45 and Fas in immune homeostasis and autoimmu-
nity. CD45 regulates lymphocyte signaling through the modu-
lation of SFK activity. SFKs control both the early activation of 
lymphocytes in response to foreign antigen and the low-level 
survival signal antigen that receptor cells produce in response to 
continuous exposure to endogenous antigens (  6, 20  ). Mutation 
of the CD45 wedge results in a hypermorphic CD45 allele that 
is more competent for signaling (  8, 10  ). Thus, instead of the 
    Figure 4.         TCR signaling and T cells contribute to lymphocyte activation and expansion.   (A) Splenic weight as an indicator of lymphoproliferation 
in normal, OT2 TCR transgenic (OT2), T cell-defi  cient (TCR         /     ), and B cell  –  defi  cient mice (Ig      /     ) comparing 2-mo-old WT and wedge/lpr. Each point rep-
resents a single mouse, fi  ve to six mice per genotype. Bars represent the mean of the group. ANOVA, P   <   0.0001. (B) Representative fl  ow cytometric anal-
ysis of CD4 memory phenotype cells in 2-mo-old OT2 TCR transgenic mice. OT2 Tg  +   cells were gated as CD3  +   CD4 +   V   2 +   V   5 + .  Tg        cells are CD3  +   CD4 +  
V    2        V   5       . Memory phenotype cells are CD44  high  , whereas naive cells are CD44  low ,  CD62L high  . Numbers represent percentage of CD4  +   cells. Data are rep-
resentative of two to four mice from three independent experiments. (C) MHC class II and CD86 expression on CD19  +   B cells and CD11c  +   DCs from 2-mo-
old TCR         /      mice, shown as the mean MFI for 4 mice per genotype   ±   SEM. Data are shown as relative MFI to correct for different antibody clones and 
fl  uorophores. Data are representative of three independent experiments. Unpaired Student  ’  s   t   test, P   <   0.05 compared with WT, *; wedge, **; and   lpr ,  ***.   2760 AUTOIMMUNITY IN CD45 WEDGE AND FAS MUTANT MICE   | Gupta et al. 
standing not only the pathogenesis of ALPS but also the roles of 
B cells and antigen receptor cell responses to endogenous anti-
gens in other autoimmune conditions. 
    MATERIALS AND METHODS   
  Mice.     CD45 E613R mice, backcrossed at least nine generations to C57BL/6, 
were bred to C57BL/6   lpr   and C4 knockout mice (The Jackson Laboratory). 
OT2 mice were a gift from M. Peters (University of California, San Francisco, 
San Francisco, CA). C57BL/6 TCR            /       and      MT mice were obtained from 
The Jackson Laboratory. Mice were bled monthly for serum antibody analysis. 
All animals were housed in a specifi  c pathogen  –  free barrier facility at UCSF, 
and experimental protocols in this research involving mice were approved by 
the UCSF Committee for Animal Research (CAR) according to guidelines 
set by the University of California San Francisco Institutional Animal Care 
and Use Committee and National Institutes of Health. 
  Autoantibody assays.     For ANA analysis, sera was diluted 1:40 in PBS/1% 
FBS and applied to Hep2 ANA slides (iNOVA) for 30 min at room temper-
ature. Slides were washed and incubated with FITC anti  –  mouse IgG, and 
images were captured using a Marianis system with a Sensicam cooled 
charge-coupled device camera (Cooke) attached to an Axiovert microscope. 
Anti-dsDNA antibody titers were determined by ELISA, as previously de-
scribed (  10  ). Serum was diluted 1:100 in blocking buff  er, and then diluted in 
twofold steps up to seven times. Pooled MRL/  lpr   serum was used as a posi-
tive control. 
  Histology.     Tissue for H  &  E staining was fi  xed in 10% formalin (Thermo 
Fisher Scientifi   c) for at least 24 h, embedded in paraffi   n,  sectioned,  and 
stained. For immunohistochemistry, tissue was immersed in OCT, snap fro-
zen in 1,1,1,2 tetrafl  uoroethane (Thermo Fisher Scientifi  c), and cut into 5-
  μ  m sections. Slides were thawed, fi  xed in acetone, treated with 0.1% H  2  O  2  , 
and blocked according to the manufacturer  ’ s instructions (Vector Laborato-
ries). Slides were incubated with primary antibody, followed by biotinylated 
secondary antibody and ABC Reagent. Slides were incubated with DAB 
(0.05% DAB, 0.01% H  2  O  2  , and 50 mM Tris, pH 7.4), washed, dehydrated, 
and mounted. Images were captured using a DM 5000B fl  uorescent micro-
scope equipped with a DFC 350FX digital camera (both from Leica). 
  Flow cytometry and antibodies.     Pooled lymph nodes (inguinal, brachial, 
axillary, cervical, and mesenteric) and spleen were homogenized by grinding 
between frosted slides and passing through a 30-  μ  m fi  lter. Red blood cells 
were removed from spleen by ammonium chloride lysis treatment. 2   ×   10  6   
cells were stained and analyzed immediately or fi  xed in 1% paraformaldehyde 
(Electron Microscopy) for analysis the following day. Data were collected on 
either a FACSCalibur (BD) or CyAn ADP (Dako). Antibodies were conju-
gated to FITC/Alexa Fluor 488, PE, PE-Texas red, PerCP-Cy5.5, PE-Cy7, 
Pacifi  c Blue, Pacifi  c Orange, or APC/Alexa Fluor 647. Antibodies used were 
as follows: CD3, CD11b, CD11c, CD19, CD45R (B220), CD62L, CD69, 
TCR V    2, and V     5 (BD); CD86 (BioLegend); CD4, CD44, and MHC class II 
(eBioscience); and CD8 (Invitrogen). 
  In vivo BrdU incorporation.     Mice were given water containing 0.8 mg/
ml BrdU and 2% glucose for 10 d. Single-cell suspensions from lymph node 
and spleen were stained for extracellular markers with antibodies conjugated 
to FITC/Alexa Fluor 488, Pacifi  c Blue, and Pacifi  c Orange. Cells were then 
fi  xed in 70% ethanol for 30 min on ice, washed, and resuspended in 1% 
paraformaldehyde/PBS for 30 min at room temperature. Intracellular DNA 
was digested using DNase solution (50 Kunitz U/ml, 4.2 mM MgCl  2  , 0.15 M 
NaCl). Cells were washed, stained with Alexa Fluor 647  –  conjugated anti-BrdU 
(PRD-1; Invitrogen), washed again, and analyzed by fl  ow cytometry. 
  Intracellular cytokine staining.     Lymph node cells were stimulated for 5 
h with 20 ng/ml PMA and 1   μ  M ionomycin in the presence of 10   μ  g/ml 
Brefeldin A. They were washed, stained for CD3, CD4, CD8, and CD44, 
and fi  xed in 2% paraformaldehyde for 20 min at room temperature. Cells 
Together, these data suggest the presence of a positive feedback 
loop between B and T cells that lead to their mutual expansion 
(  29  ). In wedge/  lpr   mice, activated APCs, and more specifi  cally 
B cells, are responsible for initiating this loop. Wedge/  lpr   B cells 
express increased levels of the activation markers MHC class II 
and CD86, even in the absence of T cells. The elevated levels of 
these markers appear to be cell intrinsic and might make the B 
cells more eff  ective at presenting endogenous antigens. We pos-
tulate that increased presentation of endogenous antigens then 
activates autoreactive T cells. These activated T cells further ac-
tivate B cells, resulting in autoantibody production and prolifer-
ation of both cell types. 
  We have shown that the CD45 wedge mutation can act as 
a genetic modifi  er for the development of autoimmunity, but 
not in all contexts. When combined with the   lpr   mutation in 
Fas, the wedge mutation dramatically accelerates and exacer-
bates the loss of tolerance, lymphocyte activation, and lympho-
proliferation. In contrast, the wedge mutation and C4 defi  ciency 
do not cooperate despite the strong predisposition of C4 defi  -
ciency to result in a lupuslike syndrome. Interestingly, genetic 
modifi  ers may be an important factor in a human disease caused 
by Fas mutations called autoimmune lymphoproliferative syn-
drome (ALPS). Even though Fas mutations are autosomal 
dominant, parents of ALPS patients may carry the same muta-
tion but not display any symptoms (  30  ). Subtle diff  erences in 
the signaling threshold of lymphocytes from these individuals 
may account for this variable penetrance. Wedge and wedge/
  lpr   mice may therefore serve as useful tools to begin under-
    Figure 5.         T cell activation and expansion is reduced in the absence 
of B cells.   (A) Representative fl  ow cytometric analysis of CD4 memory 
phenotype cells in lymph nodes from 2-mo-old B cell  –  defi  cient (Ig      /    ) 
mice. Memory cells are CD44  high ,  CD62L low/high  ; naive cells are CD44  low , 
CD62L  high  . Data are representative of two to four mice from three inde-
pendent experiments. (B) T cell BrdU incorporation in the presence and 
absence of B cells. Normal (  n   = 2) and B cell  –  defi  cient (Ig      /    ;   n   = 4) mice 
were administered BrdU in their drinking water for 10 d. Mice were 7  –  8 
wk old. Histograms give the mean percentage of CD4 and CD8 cells posi-
tive for intracellular BrdU   ±   SEM. Data are representative of three inde-
pendent experiments. Unpaired Student  ’  s   t   test P   <   0.05 compared with 
WT, *; wedge, **; and   lpr , ***.     JEM VOL. 205, November 24, 2008  2761
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were permeabilized and stained using PE-conjugated anti  –  IL-4, anti  –  IFN-     , 
anti  –  IL-17, and anti  –  IL-10 (BD) for 60 min at room temperature. Cells 
were analyzed by fl  ow cytometry. 
  AICD assay.     Lymph node CD4 T cells were purifi  ed by MACS negative 
selection (Miltenyi Biotec) and stimulated for 3 d in plates coated with 5   μ  g/
ml anti-CD3 (2C11; Harlan) and with 1   μ  g/ml soluble anti-CD28. At the 
end of 3 d, dead cells were removed with Lympholyte (Cedarlane Laborato-
ries) according to the manufacturer  ’ s instructions. Live cells were resuspended 
at 0.5   ×   10  6  /ml with 50 U/ml IL-2 and incubated for 24 h. After 24 h, dead 
cells were again removed with Lympholyte and 0.2   ×   10  6   live cells were 
added to 96-well plates coated with 0, 0.1, and 1.0   μ  g/ml anti-CD3. Cells 
were harvested 6  –  24 h later, stained with Annexin V and 7-AAD (BD) ac-
cording to the manufacturer  ’ s instructions, and analyzed by fl  ow cytometry. 
  Proliferation.     Lymph node T cells were purifi  ed by MACS negative selec-
tion (Miltenyi Biotec) and labeled with 2.5   μ  M CFSE. 96-well plates were 
coated with 0, 0.1, 1.0, and 10   μ  g/ml of anti-CD3 (2C11) overnight at 4  °  C. 
0.5   ×   10  6   cells were added to each well with or without 1   μ  g/ml of soluble 
anti-CD28. Cells were harvested 48  –  120 h later, stained for CD4 and CD8, 
and analyzed by fl  ow cytometry. 
  Online supplemental material.    Fig. S1 demonstrates the extensive lymph-
adenopathy and abnormal kidneys in wedge/  lpr   mice. Fig. S2 shows the 
memory cell phenotype of CD8 cells in all four genotypes of mice, as well 
as CD69 expression and cytokine production in CD4 cells. Fig. S3 examines 
the AICD of WT, Wedge, and   Lpr   CD4 cells. Fig. S4 shows the results of 
analyzing wedge/  lpr   mice on the BALB background. The online supple-
mental material is available at http://www.jem.org/cgi/content/full/jem
.20081204/DC1. 
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